NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
03/30/2022
Back to search
Official data from USPTO
POLYMEDCO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
03/30/2022
Trademark type
Word
Nice classes
5
Filing date
06/01/2000
Registration date
02/19/2002
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/30/2022
Last transaction
03/30/2022
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
1980-10-00
First use in commerce
1980-10-00
Drawing code
1
Owner type
16
Owner location
CORTLANDT MANOR, NY
Examiner
PIGNATELLO, ELIZABETH
Law office
L50
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
POLYMEDCO CANCER DIAGNOSTIC PRODUCTS LLC
Polymedco, Inc.
Representatives
Jared M. Barrett Seed IP Law Group LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pre-packaged diagnostic reagents for use with chemical analyzers for clinical medical laboratory use; rapid diagnostic test kits containing diagnostic preparations for clinical medical laboratory use; reagents and assays for clinical medical use for cardiac risk markersiron transport and storagediabetes controlimmunoglobulinsnutritional statusrheumatoid/acute phase proteinscomplementtumor markers and controlscancer antigen controlshemotology controlselevated HCG controlsESR controlswhole blood control designed to monitor ESR procedures and low density lipoprotein (LDL) controls; homogeneous cholesterol assays for clinical medical use; and immunoturbidimetric assay for the measurement of ferritin in serum and plasma for clinical medical use
Publications
History of USPTO decisions and trademark events.
26 publications found
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
03/30/2022
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
03/30/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/30/2022
E89R
TEAS SECTION 8 & 9 RECEIVED
12/02/2021
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
02/19/2021
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
11/22/2017
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/10/2014
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/15/2014
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
11/21/2012
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
06/29/2011
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
06/29/2011
E89R
TEAS SECTION 8 & 9 RECEIVED
06/28/2011
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
11/15/2007
PLGL
ASSIGNED TO PARALEGAL
11/05/2007
E815
TEAS SECTION 8 & 15 RECEIVED
11/02/2007
CFIT
CASE FILE IN TICRS
03/30/2007
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/29/2006
R.PR
REGISTERED-PRINCIPAL REGISTER
02/19/2002
PUBO
PUBLISHED FOR OPPOSITION
11/27/2001
NPUB
NOTICE OF PUBLICATION
11/07/2001
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/29/2001
CNEA
EXAMINERS AMENDMENT MAILED
06/07/2001
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/12/2001
CNRT
NON-FINAL ACTION MAILED
11/02/2000
DOCK
ASSIGNED TO EXAMINER
10/26/2000
Continuous trademark protection
Get notified about every new filing that threatens POLYMEDCO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.